COLUMBIA BANKING SYSTEM INC FILES (8-K/A) Disclosing Change in Directors or Principal Officers

Edgar Glimpses |

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On June 5, 2014, Columbia Banking System, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Report") reporting the appointment of Ms. Betsy Seaton to the Board of the Company and to the Board of Directors of the Company's wholly owned subsidiary, Columbia State Bank (the "Bank"). Upon filing of the Original Report, Ms. Seaton had yet to be appointed to any committees of the Company or the Bank.

This Current Report on Form 8-K/A amends the Original Report to report that on June 25, 2014, Ms. Seaton was appointed to the Enterprise Risk Management and M&A Committees of both the Company and the Bank.

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ACMHY Ascom Holding Ag S/Adr n/a n/a n/a 0

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.